ENTITY

Argenx SE (ARGX US)

42
Analysis
Health CareNetherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
Refresh
Publication Icon
No publications yet
There aren’t any Insights right now
Back to "All"
x